A common asthma medication, taken daily by millions without a second thought, may carry within it an unexpected power against cancer. Researchers at Northwestern University have found that montelukast can disrupt the molecular trick tumors use to turn the body's own immune cells into their protectors — effectively retraining those cells to fight back. Published in Nature Cancer, the findings span five cancer types in mouse models and are bolstered by patterns observed in human patient data, suggesting the mechanism may not be confined to the laboratory. Because the drug's safety is already est
Infobae
· May 21, 2026
· health
· 3 min de lectura
High
Verificación: Caracterizado
Asthma drug shows promise halting tumor growth in mouse studies
◉
Health & Medicine
3131 artículos relacionados
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% coincidencia
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% coincidencia
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% coincidencia
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% coincidencia
Weight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clini…
infobae · 90% coincidencia
Cobertura Relacionada
Vietnam.vn · Sep 16
Fragmento de hueso en el bronquio causa bronquitis prolongada en paciente de 62 años
Un hombre de 62 años en Vietnam fue diagnosticado con un fragmento óseo alojado en su bronquio izquierdo, causando tos p…
El País · Sep 16 Madrid ataca al cirujano denunciante y reduce el escándalo a una rencilla entre médicosEl Gobierno de Ayuso ataca al médico denunciante de alteraciones en la lista de espera del Ramón y Cajal, minimizando el…
La Voz de Galicia · Sep 16 Enfermera de Urgencias advierte contra la automedicación infantil ante repunte de infeccionesUna supervisora de Urgencias advierte sobre el aumento esperado de infecciones respiratorias y gastrointestinales en niñ…
65 y más · Sep 16 Pérdida dental: consecuencias y soluciones del edentulismo totalEl doctor Eduardo Anitua, odontólogo de referencia mundial, analiza en un videopódcast las causas, consecuencias y soluc…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
Medical breakthrough in cancer treatment has no direct geopolitical implications; Northwestern's asthma drug discovery is a scientific advancement without immediate international power dynamics.
Escalation Risk
low
Confidence
HIGH
No significant geopolitical shifts. This is a domestic U.S. scientific development that may have future healthcare industry implications.
Lente Económico
📈
FDA-approved asthma drug montelukast shows potential as cancer treatment by reprogramming immune cells, potentially creating new market opportunities in oncology while affecting existing asthma medication demand.
Market Signal
bullish
Confidence
MED
Pharmaceutical/Oncology
Pharmaceutical/Respiratory
Healthcare/Medical Research
Biotechnology
Patients with asthma/allergies may face supply constraints or price increases if montelukast demand surges from cancer applications. Potential future access to repurposed, lower-cost cancer treatments could reduce oncology treatment expenses for patients.
FDA may expedite clinical trials given existing drug approval status. Patent/exclusivity considerations for new cancer indications could emerge. Healthcare systems may need to manage montelukast allocation between respiratory and oncology uses. Potential for rapid regulatory pathway (breakthrough therapy designation) if clinical trials show efficacy.